{"id":"https://openalex.org/W1973169692","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","title":"Distribution of \u03b2\u2010Adrenoceptor Blocking Drugs into Cerebrospinal Fluid in Rats","display_name":"Distribution of \u03b2\u2010Adrenoceptor Blocking Drugs into Cerebrospinal Fluid in Rats","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W1973169692","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","mag":"1973169692","pmid":"https://pubmed.ncbi.nlm.nih.gov/2869640"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0773.1986.tb00074.x","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210230610","display_name":"Acta Pharmacologica et Toxicologica","issn_l":"0001-6683","issn":["0001-6683"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmacologica et Toxicologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078829275","display_name":"Pauli Ylitalo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166825849","display_name":"Tampere University","ror":"https://ror.org/033003e23","country_code":"FI","type":"education","lineage":["https://openalex.org/I166825849"]},{"id":"https://openalex.org/I4387153886","display_name":"University of Tampere","ror":"https://ror.org/05p6qqk79","country_code":"FI","type":"education","lineage":["https://openalex.org/I166825849","https://openalex.org/I4387153886"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pauli Ylitalo","raw_affiliation_strings":["The Department of Biomedical Sciences, University of Tampere, P.O.B. 607, SF-33101 Tampere, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Department of Biomedical Sciences, University of Tampere, P.O.B. 607, SF-33101 Tampere, Finland","institution_ids":["https://openalex.org/I166825849","https://openalex.org/I4387153886"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111909304","display_name":"Inge\u2010Britt Lind\u00e9n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge\u2010Britt Lind\u00e9n","raw_affiliation_strings":["Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103434772","display_name":"Aneri Penttil\u00e4","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aneri Penttil\u00e4","raw_affiliation_strings":["Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076752390","display_name":"Heikki Vapaatalo","orcid":"https://orcid.org/0000-0003-4348-8555","observed_orcids":["https://orcid.org/0000-0003-4348-8555"]},"institutions":[{"id":"https://openalex.org/I166825849","display_name":"Tampere University","ror":"https://ror.org/033003e23","country_code":"FI","type":"education","lineage":["https://openalex.org/I166825849"]},{"id":"https://openalex.org/I4387153886","display_name":"University of Tampere","ror":"https://ror.org/05p6qqk79","country_code":"FI","type":"education","lineage":["https://openalex.org/I166825849","https://openalex.org/I4387153886"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Heikki Vapaatalo","raw_affiliation_strings":["The Department of Biomedical Sciences, University of Tampere, P.O.B. 607, SF-33101 Tampere, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Department of Biomedical Sciences, University of Tampere, P.O.B. 607, SF-33101 Tampere, Finland","institution_ids":["https://openalex.org/I166825849","https://openalex.org/I4387153886"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7593,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.68182257,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"58","issue":"1","first_page":"84","last_page":"87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11406","display_name":"Cerebrospinal fluid and hydrocephalus","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11406","display_name":"Cerebrospinal fluid and hydrocephalus","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.11289999634027481,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-adrenoceptor-blocking-drugs","display_name":"beta-adrenoceptor blocking drugs","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-distribution","display_name":"cerebrospinal fluid distribution","score":0.9169999957084656},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.9010000228881836},{"id":"https://openalex.org/keywords/alprenolol","display_name":"alprenolol","score":0.9430000185966492},{"id":"https://openalex.org/keywords/metoprolol","display_name":"metoprolol","score":0.996999979019165},{"id":"https://openalex.org/keywords/oxprenolol","display_name":"oxprenolol","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pindolol","display_name":"pindolol","score":1.0},{"id":"https://openalex.org/keywords/csf-plasma-ratio","display_name":"CSF/plasma ratio","score":0.9670000076293945},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8820000290870667},{"id":"https://openalex.org/keywords/drug-penetration-into-brain","display_name":"drug penetration into brain","score":0.7009999752044678},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.8827012777328491},{"id":"https://openalex.org/C2778499207","wikidata":"https://www.wikidata.org/wiki/Q418101","display_name":"Pindolol","level":3,"score":0.8420212268829346},{"id":"https://openalex.org/C2776271928","wikidata":"https://www.wikidata.org/wiki/Q425963","display_name":"Oxprenolol","level":3,"score":0.8226504325866699},{"id":"https://openalex.org/C2780275434","wikidata":"https://www.wikidata.org/wiki/Q201370","display_name":"Alprenolol","level":3,"score":0.7882486581802368},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6732547879219055},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.6517402529716492},{"id":"https://openalex.org/C2781280847","wikidata":"https://www.wikidata.org/wiki/Q409468","display_name":"Metoprolol","level":2,"score":0.6153858304023743},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.5375120043754578},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4867370128631592},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43604832887649536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.419556200504303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20846202969551086},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0773.1986.tb00074.x","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1986.tb00074.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210230610","display_name":"Acta Pharmacologica et Toxicologica","issn_l":"0001-6683","issn":["0001-6683"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmacologica et Toxicologica","raw_type":"journal-article"},{"id":"pmid:2869640","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2869640","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmacologica et toxicologica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W76332917","https://openalex.org/W1997949494","https://openalex.org/W1999754683","https://openalex.org/W2002276609","https://openalex.org/W2023843721","https://openalex.org/W2034761064","https://openalex.org/W2046161680","https://openalex.org/W2048291535","https://openalex.org/W2065877330","https://openalex.org/W2076093642","https://openalex.org/W2079981362","https://openalex.org/W2084469465","https://openalex.org/W2203038328","https://openalex.org/W2400340905"],"related_works":["https://openalex.org/W2164649313","https://openalex.org/W2034761064","https://openalex.org/W56690634","https://openalex.org/W2401088232","https://openalex.org/W2039157398","https://openalex.org/W2754492898","https://openalex.org/W1975195589","https://openalex.org/W1983542086","https://openalex.org/W2018154508","https://openalex.org/W2025131996"],"abstract_inverted_index":{"The":[0,21,72],"distribution":[1],"into":[2,126],"cerebrospinal":[3],"fluid":[4],"(CSF)":[5],"of":[6,43,57,63,70,80,86,92,96,120,124,141],"five":[7],"3H-":[8],"or":[9],"14C-labelled":[10],"beta-adrenoceptor":[11,75],"blocking":[12,76],"drugs":[13,77,116],"given":[14,45],"intravenously":[15],"was":[16],"studied":[17],"in":[18,48,88,98],"urethane-anaesthetized":[19],"rats.":[20],"doses":[22],"(mg/kg)":[23],"were:":[24],"alprenolol":[25],"5,":[26,30],"metoprolol":[27],"1,":[28],"oxprenolol":[29],"pindolol":[31],"0.5,":[32],"propranolol":[33,103,125],"0.1":[34],"and":[35,90],"5.":[36],"Within":[37],"15":[38],"min.":[39],"a":[40,110],"marked":[41],"fraction":[42,123],"the":[44,54,93,99,114,118,121,139],"radioactivity":[46,82],"appeared":[47],"CSF":[49,81,128],"with":[50],"all":[51],"substances.":[52],"During":[53],"follow-up":[55],"period":[56],"315":[58],"min.,":[59],"only":[60],"propranolol,":[61],"independently":[62],"dose,":[64],"caused":[65,78],"high":[66],"CSF/plasma":[67,142],"ratios":[68],"(0.54-0.73)":[69],"radioactivity.":[71],"other":[73,115],"four":[74],"levels":[79,95],"which":[83],"were":[84],"0.05-0.28":[85],"that":[87],"plasma":[89,107],"0.05-0.14":[91],"calculated":[94],"activity":[97],"whole":[100],"body.":[101],"Since":[102],"is":[104,129],"bound":[105],"to":[106,109],"proteins":[108],"higher":[111],"degree":[112],"than":[113,133],"studied,":[117],"penetration":[119],"unbound":[122],"rat":[127],"even":[130],"more":[131],"pronounced":[132],"what":[134],"would":[135],"be":[136],"expected":[137],"on":[138],"basis":[140],"ratio":[143],"measured.":[144]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}